Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
de Bock
Geertruida H
GH
Tollenaar
Rob A E M
RA
Papelard
Hadewych
H
Vliet Vlieland
Theodora P M
TP
Devilee
Peter
P
Cornelisse
Cornelis J
CJ
Vandenbroucke
Jan P
JP
D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000235:genetics; D016022:Case-Control Studies; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D016017:Odds Ratio; D018570:Risk Assessment; D012307:Risk Factors
D003278:Contraceptives, Oral, Hormonal